Hodgkin's lymphoma is one of the curable cancers and the standard treatment 
regimen involves combination chemotherapy involving bleomycin. One of the fatal 
side effect of bleomycin is pulmonary toxicity. Here we present three cases of 
Hodgkin's lymphoma treated with ABVD chemotherapy who had pulmonary toxicity. 
All three developed bleomycin induced pulmonary toxicity in the form of 
pulmonary fibrosis during treatment of the disease. Mode of treatment, severity 
of the condition and the treatment outcome varied among the three. Two recovered 
following treatment and one patient died due to irreversible pulmonary damage. 
Causality assessment using Naranjo's scale gave a score of 7 for case one and 
three and a score of 6 for case two, both indicating the adverse drug reaction 
to be a probable bleomycin induced Lung fibrosis.